🇺🇸 FDA
Patent

US 10968201

Bicyclic carboxamides and methods of use thereof

granted A61PA61P35/00

Quick answer

US patent 10968201 (Bicyclic carboxamides and methods of use thereof) held by TEMPEST THERAPEUTICS, INC. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEMPEST THERAPEUTICS, INC.
Grant date
Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00